MedTrace Logo

InfluenCEF Study: Study on the Headache Associated With Influenza Infection

NCT05704335 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-02-14

No results posted yet for this study

Summary

The goal of this observational analytic study with a cohort desing is to evaluate the epidemiology, risk factors and clinical phenotype of headache during Influenza infection. The study will be done in collaboration with the Healthcare Sentinel Network of Castile and Leon (Red Centinela Sanitaria de Castilla y León, RCSCYL) and the National Influenza Center of Valladolid (CNGV). First, the historical data of the VIGIRA network of the 2010-2022 flu seasons will be analyzed, assessing the epidemiology and risk factors of headache during Influenza infection; and second, a study with a case series design with prospective follow-up will be carried out for the incident cases of the 2022-2023 and 2023-2024 Influenza seasons, evaluating the clinical phenotype and the duration of the headache.

Conditions

Interventions

OTHER

Questionnaire administration

A trained physician will administer a structured questionnaire

Sponsors & Collaborators

  • Red Centinela Sanitaria de Castilla y León (RCSCYL)

    collaborator UNKNOWN

  • Centro Nacional de Gripe de Valladolid (CNGV)

    collaborator UNKNOWN

  • Dirección General de Salud Pública de la Consejería de Sanidad de la Junta de Castilla y León

    collaborator UNKNOWN

  • Hospital Clínico Universitario de Valladolid

    lead OTHER

Principal Investigators

  • David García Azorín, MD, PhD · Sanidad de Castilla y León

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2024-04-30
Completion
2024-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704335 on ClinicalTrials.gov